Headline
The latest stories from AHA Today.
The Centers for Medicare & Medicaid Services announced the extension of its Appropriate Use Criteria testing period through 2021.
Health and Human Services posted COVID-19 testing plans for state, local and territorial jurisdictions through the rest of calendar year 2020.
The Food and Drug Administration approved the first liquid biopsy companion diagnostic that uses next-generation sequencing technology to identify patients with specific gene mutations in a deadly form of metastatic non-small cell lung cancer.
The AHA urged the Internal Revenue Services to remove the treatment of health care sharing ministries from a proposed rule issued by the agency in June.
President Trump authorized the Federal Emergency Management Agency to use up to $44 billion in Stafford Act disaster relief funds to supplement individuals’ wages resulting from lost work due to the COVID-19 public health emergency.
The Food and Drug Administration revoked its emergency use authorization for a SARS-CoV-2 antibody test made by Autobio Diagnostics Co. due to concerns with the accuracy of the test when evaluated at the National Institutes of Health’s Frederick National Laboratory for Cancer Research.
The Health Resources and Services Administration expects in mid-August to distribute half of the $5 billion in Provider Relief Funds announced last month to enhance COVID-19 response at Medicare-certified long-term care facilities, the agency said Friday.
In an op-ed published in Fierce Healthcare, Robyn Begley, AHA’s chief nursing officer and CEO of the American Organization for Nursing Leadership, urged Americans to take steps to defeat COVID-19 by adopting the mindset employed in every hospital and health system nationwide.
The health care field added 125,500 jobs in July, increasing nearly 1% to a seasonally adjusted 15.7 million, the Bureau of Labor Statistics reported.
The Health Resources and Services Administration awarded 89 organizations, including hospitals, $1 million each to combat opioid and other substance use disorders in high-risk rural communities. The recipients will work with the communities to implement and tailor evidence-based or promising…